FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

24605011000001106: Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
79953401000001119 Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79953501000001115 Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Is a Mometasone 50micrograms/dose nasal spray true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Is a Mometasone furoate monohydrate 0.05% aqueous nasal spray false Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has active ingredient Mometasone furoate monohydrate true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has manufactured dose form Conventional release nasal spray true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has specific active ingredient Mometasone furoate true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Is a Mometasone 50micrograms/dose nasal spray false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) 140 dose Has AMP True Mometasone 50micrograms/dose nasal spray (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start